
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Feb 11, 2026 01:47 am UTC| Business
Commonwealth Bank of Australia (ASX: CBA) shares jumped sharply on Wednesday after the countrys largest lender reported record-high cash earnings for the half year ended December, boosting investor confidence despite...

FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Feb 11, 2026 01:46 am UTC| Governance Business Health
The U.S. Food and Drug Administration (FDA) has declined to review Modernas approval application for its experimental influenza vaccine, mRNA-1010, a decision that sent the companys shares down about 8% in extended...

Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Feb 11, 2026 01:43 am UTC| Business
Brazils state-run oil company Petrobras reported record-breaking oil and derivatives exports of 1.2 million barrels per day (bpd) in the fourth quarter, marking a sharp increase of nearly 79% compared with the same period...

Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Feb 11, 2026 01:41 am UTC| Business Technology
Cloudflare has projected annual and first-quarter revenue above Wall Street expectations, signaling strong confidence in the growing demand for cloud services driven by rapid advancements in artificial intelligence. The...

Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Feb 11, 2026 01:37 am UTC| Business
Lyft shares fell sharply in after-hours trading after the ride-hailing company forecast first-quarter adjusted core profit below Wall Street expectations, citing severe U.S. winter weather, seasonal cost pressures, and a...

xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Feb 11, 2026 01:33 am UTC| Business Technology
Jimmy Ba, a co-founder of xAI, announced on Tuesday evening that he is leaving the artificial intelligence startup, becoming the sixth founding member to exit the company in recent months. Ba shared the news in a post on...

Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Feb 11, 2026 01:30 am UTC| Business Health Governance
Moderna Inc. (NASDAQ: MRNA) shares declined sharply in after-hours trading on Tuesday after the biotechnology company disclosed that the U.S. Food and Drug Administration (FDA) has declined to review its influenza vaccine...